Leitlinie
China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement
Journal of European Competition Law & Practice · 31.07.2026
DOI: 10.1093/jeclap/lpag047 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of European Competition Law & Practice, online erschienen am 31.07.2026. Verfasst von Qiang Yu.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yu, Q. (2026). China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement. Journal of European Competition Law & Practice. https://doi.org/10.1093/jeclap/lpag047
Vancouver
Yu Q. China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement. Journal of European Competition Law & Practice. 2026. doi:10.1093/jeclap/lpag047
BibTeX
@article{Yu2026,
author = {Yu, Qiang},
title = {China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement},
journal = {Journal of European Competition Law & Practice},
year = {2026},
doi = {10.1093/jeclap/lpag047}
}
EUVIMED